Product Details
SARS-CoV-2 Nucleic Acid Test Kit (RT-PCR)
Principle
This kit is based on real-time PCR fluorescence technology to
detect the COVID-19 nucleic acid
of patients with Flu-like symptoms, patients with severe pneumonia
or patients with asymptomatic infection.
The operators should have professional training of gene
amplification or molecular biologicalmethod detection,
have the relevant experimental operation qualification, and the
laboratory shallhave reasonable biological safety
prevention facilities and protection procedures.
Components
2019-nCov Mix
Enzyme Mix
Negative Control
Positive Control
Applicable Instrument
A real-time PCR instrument containing at least four colors
fluorescence channels, such as SLAN-96P, ABI 7500, Roche Light
Cycle 480.
Company Profile
Shenzhen Kisshealh Biotechnology Co., Ltd., located in the Pingshan
District, Shenzhen, P.R. China. is a diagnostics company focused on
the development and manufacture of IVD tests at the Point-of-Care
with highly innovative proprietary technology.
We focused on the emerging markets of in vitro pathological
diagnosis and immunodiagnosis. We developed, manufactured and
successfully launched the in vitro immunodiagnosis platform for
cancer and the POCT for infectious, genetic and chronic diseases.
<span style="color: rgb(33, 33, 33); text-transform: none;
text-indent: 0px; letter-spacing: normal;" initial;"="" initial;=""
0px;="" normal;="" 255);="" 255,="" rgb(255,="" 2;=""
!important;="" inline="" none;="" 600;="" 14px;="" sans-serif;=""
arial,="" roboto,="" w3",="" gb="" sans="" "hiragino="" gb",=""
hei",="" micro="" "wenquanyi="" sans",="" "droid="" arimo,=""
freesans,="" yahei",="" "microsoft="" helvetica,="" grande",=""
"lucida="" ui",="" segoe="">At Kissh we work every day to shape
the future of in-vitro diagnostic testing. And our people are our
best asset, the reason for our track record and our strength while
we are moving forward. We live by our fundamental values and
incorporate them in everything that we do. Our best asset is ‘Step
Forward Every Second’